Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 10 Lung Neoplasms 9 Colorectal Neoplasms 7 Breast Neoplasms 7 Prostatic Neoplasms 6 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Stomach Neoplasms 2 Smoking Cessation 2 Neoplastic Cells, Circulating 2 Motor Activity 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Disease 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stroke 1 Solitary Pulmonary Nodule 1 Skin Neoplasms 1 Sezary Syndrome 1

Interventions

Sorafenib 2 nimotuzumab 1 lenvatinib 1 atezolizumab 1 Stents 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Immune Checkpoint Inhibitors 1 Hematologic Tests 1 Ethiodized Oil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HCC × Hematologic Tests × Clear all

NCT05825196 2023-04-24

Study of Serum Tumor Markers of HBV Associated HCC

Qianfoshan Hospital

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡